$INCY 4/A SEC Filings

Filed On	Filing
20 May 2026	Form 4/A: Stein Steven H, CMO & Head of Late-Stage Dev. Received 44,124 shares as a grant or award
20 May 2026	Form 4/A: Cagnoni Pablo J, President, Global Head of R&D Received 31,517 shares as a grant or award
21 Jun 2023	Form 4/A: Cagnoni Pablo J, President, R&D Received 192,400 shares as a grant or award
02 Mar 2009	Form 4/A: 14159 capital (GP), Llc, Director and 2 others Acquired 212,000 3.5% Subordinated Convertible Note due 2011 (Open Market Purchase) ($10.5M) · Acquired 138,000 3.5% Subordinated Convertible Note due 2011 (Open Market Purchase) ($6.79M) · Bought 927 shares ($2K) · 1 more
02 Mar 2009	Form 4/A: Baker Brothers Life Sciences Capital (GP), Llc, Director and 2 others Acquired 7,627,000 3.5% Subordinated Convertible Note due 2011 (Open Market Purchase) ($376M) · Acquired 4,962,000 3.5% Subordinated Convertible Note due 2011 (Open Market Purchase) ($244M) · Bought 33,364 shares ($71.8K) · 1 more
22 Dec 2008	Form 4/A: Baker Biotech Capital (GP), Llc, Director and 2 others Bought 69,566 shares ($231K) · Bought 68,463 shares ($244K) · Acquired 729,000 3.5% Senior Convertible Note due 2011 (Open Market Purchase) ($38.5M) · 4 more
22 Dec 2008	Form 4/A: Baker Bros. Capital (GP), Llc, Director and 2 others Bought 309 shares ($1.03K) · Bought 133 shares ($474) · Acquired 1,000 3.5% Senior Convertible Note due 2011 (Open Market Purchase) ($52.8K) · 3 more
22 Dec 2008	Form 4/A: 14159 capital (GP), Llc, Director and 2 others Bought 6,061 shares ($20.2K) · Bought 6,252 shares ($22.3K) · Acquired 66,000 3.5% Senior Convertible Note due 2011 (Open Market Purchase) ($3.49M) · 4 more
22 Dec 2008	Form 4/A: Baker Brothers Life Sciences Capital (GP), Llc, Director and 2 others Bought 221,814 shares ($738K) · Bought 228,972 shares ($816K) · Acquired 2,436,000 3.5% Senior Convertible Note due 2011 (Open Market Purchase) ($129M) · 4 more
22 Dec 2008	Form 4/A: Baker / Tisch Capital (GP), Llc, Director and 2 others Bought 1,501 shares ($4.99K) · Bought 1,628 shares ($5.8K) · Acquired 18,000 3.5% Senior Convertible Note due 2011 (Open Market Purchase) ($951K) · 3 more
19 Dec 2008	Form 4/A: 14159 capital (GP), Llc, Director and 2 others Bought 6,061 shares ($20.2K) · Bought 6,252 shares ($22.3K) · Bought 7,772 shares ($28K) · 2 more
19 Dec 2008	Form 4/A: Baker Brothers Life Sciences Capital (GP), Llc, Director and 2 others Bought 221,814 shares ($738K) · Bought 228,972 shares ($816K) · Bought 284,546 shares ($1.02M) · 2 more
12 Dec 2007	Form 4/A: Baker / Tisch Capital (GP), Llc, Director and 1 other Bought 2,265 shares ($21.6K) · Bought 3,224 shares ($31.8K) · Bought 3,560 shares ($37K)
12 Dec 2007	Form 4/A: Baker Biotech Capital (GP), Llc, Director and 1 other Bought 42,843 shares ($409K) · Bought 61,006 shares ($602K) · Bought 67,353 shares ($699K)
16 Nov 2007	Form 4/A: Baker / Tisch Capital (GP), Llc, Director and 1 other Bought 446 shares ($3.8K) · Bought 382 shares ($3.29K) · Bought 225 shares ($1.87K)
13 Aug 2004	Form 4/A: Tisch Thomas J, No longer 10% owner. Bought 255,750 shares ($1.41M)
13 Aug 2004	Form 4/A: Tisch James S, No longer 10% owner. Bought 255,750 shares ($1.41M)
13 Aug 2004	Form 4/A: Tisch Andrew H, No longer 10% owner. Bought 255,750 shares ($1.41M)
13 Aug 2004	Form 4/A: Tisch Daniel R, No longer 10% owner. Bought 255,750 shares ($1.41M)
02 Jun 2004	Form 4/A: Craves Fred B, Director Granted 10,000 Non-Qualified Stock Options

Comments